ArticleClinical Medicine Insights. Oncology2022
Corrigendum to GRHL2 expression functions in breast cancer aggressiveness and could serve as prognostic and diagnostic biomarker for breast cancer.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.